tiprankstipranks
Advertisement
Advertisement
Xilio Therapeutics announces inducement grants
PremiumThe FlyXilio Therapeutics announces inducement grants
1M ago
XLO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
XLO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
Xilio Therapeutics Shareholders Approve Flexible Reverse Stock Split
Premium
Company Announcements
Xilio Therapeutics Shareholders Approve Flexible Reverse Stock Split
1M ago
Xilio Therapeutics Approves 2025 Stock Incentive Plan
PremiumCompany AnnouncementsXilio Therapeutics Approves 2025 Stock Incentive Plan
4M ago
Xilio Therapeutics Reports Revenue Growth Amidst Challenges
Premium
Company Announcements
Xilio Therapeutics Reports Revenue Growth Amidst Challenges
5M ago
Xilio Therapeutics expects cash to fund operations into Q1 of 2027
Premium
The Fly
Xilio Therapeutics expects cash to fund operations into Q1 of 2027
5M ago
Xilio Therapeutics Initiates Phase 2 Trial for XTX301
PremiumCompany AnnouncementsXilio Therapeutics Initiates Phase 2 Trial for XTX301
7M ago
Xilio Therapeutics announces initiation of Phase 2 trial for efarindodekin alfa
Premium
The Fly
Xilio Therapeutics announces initiation of Phase 2 trial for efarindodekin alfa
7M ago
Xilio Therapeutics sees cash runway into 1Q27
Premium
The Fly
Xilio Therapeutics sees cash runway into 1Q27
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100